Related Experiment Video
Updated: May 7, 2026
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression
Agnieszka Fiszer1, Marta Olejniczak, Paulina Galka-Marciniak
1Department of Molecular Biomedicine, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.
Insights
Researchers developed novel silencing reagents targeting the CAG repeat expansion in Huntington's disease (HD). These self-duplexing CUG repeat short interfering RNAs selectively inhibit mutant huntingtin gene expression, offering a promising therapeutic strategy for HD patients.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Huntington's disease (HD) is a fatal neurodegenerative disorder.
- It stems from a CAG repeat expansion in the HTT gene, producing toxic mutant huntingtin protein.
- Current treatments for HD are limited, highlighting the need for novel therapeutic approaches.
Purpose of the Study:
- To develop and evaluate a new class of CAG repeat-targeting silencing reagents.
- To assess the allele and gene selectivity of these novel reagents.
- To investigate the therapeutic potential of inhibiting mutant huntingtin allele expression.
Main Methods:
- Designed self-duplexing CUG repeat-targeting short interfering RNAs (siRNAs).
- Induced self-duplex formation via U-base substitutions.
- Tested siRNA efficacy and selectivity in patient-derived cells via transfection.
- Evaluated short hairpin RNA (shRNA) vectors for sustained gene silencing.
Main Results:
- Developed novel self-duplexing CUG repeat siRNAs with distinct activity profiles.
- Achieved high allele selectivity, differentiating between normal and mutant HTT alleles.
- Demonstrated significant gene selectivity, distinguishing HTT transcripts from those with shorter CAG repeats.
- Confirmed the use of the RNA interference pathway for gene silencing.
- Showed comparable efficacy and selectivity using shRNA vectors for durable silencing.
Conclusions:
- Self-duplexing CUG repeat siRNAs represent a promising therapeutic strategy for Huntington's disease.
- These reagents offer high selectivity for targeting mutant HTT alleles.
- RNA interference mediated by these novel reagents can effectively reduce mutant huntingtin expression.
Abstract:
Huntington's disease (HD) is a neurodegenerative genetic disorder caused by the expansion of the CAG repeat in the translated sequence of the HTT gene. This expansion generates a mutant huntingtin protein that contains an abnormally elongated polyglutamine tract, which, together with mutant transcript, causes cellular dysfunction. Currently, there is no curative treatment available to patients suffering from HD; however, the selective inhibition of the mutant allele expression is a promising therapeutic option. In this study, we developed a new class of CAG repeat-targeting silencing reagents that consist of self-duplexing CUG repeats. Self-duplex formation was induced through one or several U-base substitutions. A number of self-duplexing guide-strand-only short interfering RNAs have been tested through transfection into cells derived from HD patients, showing distinct activity profiles. The best reagents were highly discriminatory between the normal and mutant HTT alleles (allele selectivity) and the HTT transcript and other transcripts containing shorter CAG repeats (gene selectivity). We also demonstrated that the self-duplexing CUG repeat short interfering RNAs use the RNA interference pathway to elicit silencing, and repeat-targeting reagents showed similar activity and selectivity when expressed from short hairpin RNA vectors to achieve more durable silencing effects.
More Related Videos
Related Concept Videos
01:21Huntington Disease l: Introduction
02:27Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...